Judesio medicina - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 56,541 | 53,789 | 51,000 | 48,285 | 47,711 | 64,797 | 78,118 | 143,817 |
| Profit before tax | 11,765 | 11,760 | 9,600 | 1,240 | -5,676 | 22,233 | 22,085 | 42,309 |
| Net profit | 11,468 | 11,155 | 9,120 | 1,168 | -5,676 | 21,312 | 21,033 | 39,737 |
| Equity | 25,402 | 36,557 | 40,751 | 32,039 | 16,481 | 37,792 | 39,505 | 63,242 |
| Liabilities | - | - | - | - | 7,530 | 186 | 6,514 | 32,338 |
| Non-current assets | 15,124 | 13,208 | 25,630 | 17,086 | 11,340 | 10,736 | 10,123 | 27,374 |
| Current assets | 25,963 | 25,159 | 24,142 | 21,174 | 12,671 | 27,242 | 35,896 | 67,224 |
| Total assets | 41,087 | 38,367 | 49,772 | 38,260 | 24,011 | 37,978 | 46,019 | 94,598 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 377 | 5,666 | 12,957 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +45.4% | -4.9% | -5.2% | -5.3% | -1.2% | +35.8% | +20.6% | +84.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 27.9% | 29.1% | 18.3% | 3.1% | -23.6% | 56.1% | 45.7% | 42.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 45.1% | 30.5% | 22.4% | 3.6% | -34.4% | 56.4% | 53.2% | 62.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 20.3% | 20.7% | 17.9% | 2.4% | -11.9% | 32.9% | 26.9% | 27.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 20.8% | 21.9% | 18.8% | 2.6% | -11.9% | 34.3% | 28.3% | 29.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | 0.5 | 0.0 | 0.2 | 0.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 33,924 | 16,550 | 19,125 | 17,042 | 23,856 | 32,399 | 39,059 | 59,510 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Judesio medicina - Social security debts
The company had no debts to Sodra
Judesio medicina - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-08-10 | 2026-08-10 | 1289.68 |
| 2026-08-07 | 2026-08-09 | 1288.69 |
| 2026-08-05 | 2026-08-06 | 1239.38 |
| 2024-08-29 | 2024-10-16 | 0.19 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Judesio medicina, MB (code 304405814) is a Small partnership engaged in Physiotherapy activities. In 2025, the company generated €143.8K in revenue, which was 84.1% higher year on year and 122.0% above the 2023 level. Net profit increased to €39.7K, with a profit margin of 27.6%. The revenue and profit trend shows a steady base in 2023 and 2024, followed by a marked expansion in 2025, when revenue nearly doubled compared with 2024. Total assets rose to €94.6K in 2025 from €46.0K in 2024 and €38.0K in 2023, while equity increased to €63.2K. Liabilities also grew to €32.3K from €6.5K a year earlier, but equity still accounted for 66.8% of assets. Key efficiency indicators remained strong, with asset turnover at 1.52x, ROE at 62.8% and ROA at 42.0%. Revenue per employee reached €71.9K and profit per employee €19.9K, indicating solid productivity in 2025.